<DOC>
	<DOC>NCT00658580</DOC>
	<brief_summary>The purpose of this study is to determine if a cisplatin-etoposide regimen improves survival in comparison to a regimen containing etoposide and without platinum derivative.</brief_summary>
	<brief_title>Randomized Study of Cisplatin-Etoposide Versus an Etoposide Regimen Without Cisplatin in Extensive Small-Cell Lung Cancer</brief_title>
	<detailed_description />
	<mesh_term>Small Cell Lung Carcinoma</mesh_term>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Etoposide phosphate</mesh_term>
	<mesh_term>Isophosphamide mustard</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Etoposide</mesh_term>
	<mesh_term>Epirubicin</mesh_term>
	<mesh_term>Ifosfamide</mesh_term>
	<criteria>Histological or cytological diagnosis of smallcell lung cancer Extensive disease (i.e. a disease with distant metastases or that cannot be included in a single irradiation field incorporating primary tumour, mediastinum and supraclavicular lymph node(s)) Availability for participating in the detailed followup of the protocol Presence of an evaluable or measurable lesion Informed consent Prior treatment with chemotherapy, radiotherapy or surgery Performance status &lt; 60 on the Karnofsky scale A history of prior malignant tumor, except nonmelanoma skin cancer or in situ carcinoma of the cervix or a cured cancer (defined as a diseasefree interval &gt; 5 years) White blood cells &lt; 4000/mm3 Platelets &lt; 100000/mm3 Serum bilirubin &gt; 1.5 mg/100 ml Serum creatinine &gt; 1.3 mg/100 ml and creatinine clearance &lt;60 ml/min Recent myocardial infarction (less than 3 months prior to date of diagnosis) Congestive cardiac failure or cardiac arrhythmia uncontrolled by medical treatment Uncontrolled infectious disease Serious medical or psychological factors which may prevent adherence to the treatment schedule</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2015</verification_date>
	<keyword>Small cell lung carcinoma</keyword>
	<keyword>Chemotherapy</keyword>
	<keyword>Phase III randomised study</keyword>
</DOC>